Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
Sector - Healthcare
Equity
-
Last updated on 2023-01-23
3Y returns
+17.31%
| ₹14.60 Latest NAV | ₹0.13 1D Change | ₹461.70 AUM |
|---|---|---|
| Very High Risk Risk Profile | ₹500 Min SIP | ₹1000 Min Lumpsum |
| None Lock-in period | 1.04% Expense Ratio | 1.0% before 30 Days Exit Load |
Price Chart
-5.73 1Y return
Loading...
Top Holdings
Sun Pharmaceuticals Industries Ltd
16.97%
Cipla Ltd
9.64%
Apollo Hospitals Enterprise Ltd
9.11%
Dr Reddy's Laboratories Ltd
6.85%
Lupin Ltd
5.32%
View All
Sector Breakdown
Healthcare
94.46%
Basic Materials
1.21%
Consumer Defensive
0.96%
Fund Manager
Dhaval Shah
Investment Objective
The scheme provides long term capital appreciation by investing in equity/equity
related instruments of the companies in the Pharmaceuticals, Healthcare and Allied
sectors in India.
The Scheme does not guarantee/indicate any returns. There can be no
assurance that the schemes’ objectives will be achieved.
Download Scheme Document